ArticleAmerican journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics2026
Longitudinal outcomes of bone-anchored maxillary protraction treatment.
Article in American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionBone-anchored maxillary protraction (BAMP) is a well-tolerated treatment for Class III orthopedic effects during adolescence. BAMP aims to improve Class III skeletal relationships with minimal dentoalveolar compensations, in the hope of reducing the need for orthognathic surgery. Our aim was to evaluate the short- and long-term effects of BAMP on measures of tooth and jaw positions and definitive treatment outcomes in patients with Class III malocclusion treated with (+) and without (-) BAMP during adolescence.
methodsPatients treated with BAMP (n = 45) in adolescence were compared with an adolescent Class III control group (n = 39) before comprehensive treatment. Lateral cephalograms were used to quantify skeletal and dental relationships at initial records (T0, before BAMP or growth observation) and at comprehensive initial records (T1) and final comprehensive records (T2). Patients were categorized by their definitive treatment modality: surgical, with 1-jaw and 2-jaw subcategories, or camouflage, with extraction and nonextraction subcategories.
resultsData indicate that BAMP+ patients had improvements in skeletal measures, including SNA (P = 0.001), ANB (P < 0.0001), and Wits appraisal (P = 0.0001), compared with controls after phase 1 treatment. Between T1 and T2, changes in ANB (P = 0.019), Wits appraisal (P = 0.001), and B-N Vert (P = 0.02) indicate a greater worsening of Class III malocclusion in the BAMP+ group, suggesting additional growth. At the end of comprehensive treatment, BAMP+ patients had a higher ANB (P = 0.026) and A-N Perp (P = 0.012) than controls, whereas controls had greater maxillary incisor protrusion (P = 0.0072) and proclination (P = 0.047). There was no difference in the prevalence or type of orthognathic surgery. Among patients treated with orthodontic camouflage, controls (55.17%) underwent extractions more often than BAMP+ patients (21.05%, P = 0.003).
conclusionsThere is modest improvement in maxillary position associated with BAMP, with a limited effect on dentoalveolar outcomes. BAMP did not influence the comprehensive treatment modality (surgical vs camouflage). However, controls with camouflage were over twice as likely to have extractions compared to BAMP+ patients. Our findings suggest that BAMP may reduce extractions, with a limited effect on the frequency of orthognathic surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.